Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

Summary Background Chronic urticaria (CU) is a common skin condition. It is frequently a disabling disease due to the persistency of clinical symptoms, the unpredictable course and negative influence on the quality of life. Objective The aim of this study is to determine whether montelukast, a LTD4...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental allergy 2004-09, Vol.34 (9), p.1401-1407
Hauptverfasser:	Nettis, E., Colanardi, M. C., Paradiso, M. T., Ferrannini, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetates - administration & dosage Administration, Oral Adolescent Adult Aged Allergic diseases Biological and medical sciences Chronic Disease chronic urticaria desloratadine Double-Blind Method Drug Therapy, Combination Female Fundamental and applied biological sciences. Psychology Fundamental immunology Histamine H1 Antagonists, Non-Sedating - administration & dosage Humans Immunopathology Leukotriene Antagonists - administration & dosage Loratadine - administration & dosage Loratadine - analogs & derivatives Male Medical sciences Middle Aged montelukast placebo-controlled Pruritus - drug therapy Pruritus - pathology Quality of Life Quinolines - administration & dosage Severity of Illness Index Skin allergic diseases. Stinging insect allergies Treatment Outcome Urticaria - drug therapy Urticaria - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!